ADAMTS6 expression was significantly associated with the 5-year DFS of BC patients in our study, but did not correlate with patient age, tumor size, histological grade, molecular subtype, or lymph node metastasis. The gene discussed is ADAMTS6; the disease is metastatic malignant neoplasm in the lymph nodes.